Literature DB >> 18458960

[Methodological fundamentals for the development of the guideline].

K Bernardy1, P Klose, N Uçeyler, I Kopp, W Häuser.   

Abstract

The guideline was developed by 10 scientific societies and 2 patient self-help organizations and coordinated by the German Association of Pain Therapy (DIVS). The guideline was approved by the Association of the Scientific Medical Societies in Germany AWMF (AWMF number 041/004), april 17, 2008. No direct or indirect financial support by pharmaceutical companies was involved and there were no potential conflicts of interest for any of the 58 participants of the guideline group. The results of a systematic search of the literature (Cochrane Library [1993-12/2006], Medline [1980-12/2006], PsychInfo [1966-12/2006] and Scopus [1980-12/2006]) were analyzed by 8 working groups. A balanced composition of the working groups as to sex, level of medical care and position in medical or scientific hierarchy of their members was realized. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was done according to the German program for disease management guidelines. Standardized, formal procedures to reach a consensus on recommendations were used. The guideline was reviewed by the board of directors of the societies engaged in the development of the guideline. The guideline will be published in complete and short scientific versions, clinical practice and patient versions.

Entities:  

Mesh:

Year:  2008        PMID: 18458960     DOI: 10.1007/s00482-008-0670-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  3 in total

1.  [Methodological basis for the development of consensus recommendations].

Authors:  J C Hoffmann; I Fischer; W Höhne; M Zeitz; H-K Selbmann
Journal:  Z Gastroenterol       Date:  2004-09       Impact factor: 2.000

2.  Rules of evidence and clinical recommendations on the use of antithrombotic agents.

Authors:  D L Sackett
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

Review 3.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

  3 in total
  14 in total

1.  [Methodological fundamentals of the development of the guideline].

Authors:  W Häuser; K Bernardy; H Wang; I Kopp
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 2.  [Recommendations for treatment of fibromyalgia : Where will we stand in 10 years?]

Authors:  K Thieme; D C Turk
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

3.  [Visualization of a myth--the new S3 guidelines for fibromyalgia syndrome].

Authors:  B Widder
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

4.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 5.  An overview of treatment approaches for chronic pain management.

Authors:  Nicholas Hylands-White; Rui V Duarte; Jon H Raphael
Journal:  Rheumatol Int       Date:  2016-04-23       Impact factor: 2.631

6.  [Methodology report of the 2017 guidelines on fibromyalgia syndrome].

Authors:  W Häuser; M Nothacker
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

7.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

8.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

9.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

10.  [Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain].

Authors:  A Klement; W Häuser; W Brückle; U Eidmann; E Felde; M Herrmann; H Kühn-Becker; M Offenbächer; M Settan; M Schiltenwolf; M von Wachter; W Eich
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.